This page includes the latest FDA filings for Spark Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2024-04-18 |
Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2022-06-24 |
Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2020-01-15 |
Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2019-09-25 |
Spark Therapeutics, Inc., BioReliance Corporation, Pharmaceutical Product Development, Inc. (PPD), Absorption Systems, Eurofins (Lancaster Laboratories), Intertek Pharmaceutical Services, Nova Laboratories Ltd, Catalent Pharma Solutions, Hologic Ltd Tepnel Pharma | Prescription Medication | 2019-06-26 |
Spark Therapeutics, Inc. | LUXTURNA | 2017-12-19 |
NCAGE Code | 7CUR0 | SPARK THERAPEUTICS, INC. |
CAGE Code | 7CUR0 | SPARK THERAPEUTICS, INC. |
S.A.M. Registration | 7CUR0 [79498241] | SPARK THERAPEUTICS, INC. |
DUNS | 079498241 | Spark Therapeutics, Inc. |
SEC | 0001609351 | Spark Therapeutics, Inc. of DELAWARE |